SCIENTIFIC BACKGROUND

DSC2, DSG2, DSP, JUP, LMNA, PKP2, TGFB3, TMEM43

Arrythmogenic right ventricular cardiomyopathy (ARVC) is a mostly autosomal dominant inherited disease of the heart muscle in which the myocardium is progressively replaced by fatty and connective tissue. The connective tissue remodeling, which mainly affects the right ventricle, initially leads to a disturbance of the stimulus conduction with ventricular arrythmias, palpitations or syncope. The ECG typically shows epsilon waves and an inverted T-wave with broadened QRS complex in right precordial recording.

 

The arrythmias that can lead to sudden cardiac death are usually triggered by physical exertion. About one third of the index patients die suddenly between the ages of 14-20 years and this age seems to be a vulnerable period for fatal arrythmias. However, half of the carriers do not develop clinical symptoms until over 50 years of age and about one third do not become ill until old age. The frequency of ARVC is estimated at 1:5,000, and about half of the cases show a familial clustering. More than ten different forms of ARVC have now been documented.

 

The most common forms are caused by variants in genes that code for components of the desmosomes (cell-cell connections). Molecular genetic analysis of the genes that encode desmoplakine (DSP), plakophilin-2 (PKP2) and desmoglein-2 (DSG2) reveals variants in about 50-60% of patients. In about 5% of cases, the hereditary form of ARVC is caused by variants of other desmosomal protein genes such as plakoglobin (JUP) and desmocollin-2 (DSC2), as well as other genes such as transmembrane protein 43 (TMEM43) and transforming growth factor beta-3 (TGFB3). To date, no genetic cause can be proven in about 40% of ARVC cases.

 

References

Hall et al. 2018, Eur J Hum Genet doi.org/10.1038/s41431-018-0169- 4 / Walsh et al. 2017, Genet Med 19:192 / Medeiros-Domingo et al. 2016, Europace pii: euw098 / Bhonsale et al. 2015, Eur Heart J epub Jan / Schulze-Bahr et al. 2015, Kardiologe DOI 10.1007/s12181-014-0636-2 / Campuzano et al. 2013, J Med Genet 50:280 / Quarta et al. 2011, Circulation 123:2701 / Ackerman et al. 2011, Europace 13:1077

GENES

DSC2, DSG2, DSP, JUP, LMNA, PKP2, TGFB3, TMEM43
How to order

LATEST ARTICLES

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more